Company Active LTD

Company profile

Psephos Limited

UK company 04148007, incorporated on 25 January 2001.

Psephos Limited is a UK company with status Active founded in 2001 based in South East England.

Company number
04148007
Incorporated
25 Jan 2001
Companies House status
Active

Company identity

Founded / incorporated
25 January 2001

Company number 04148007

Verify at Companies House
Legal name
PSEPHOS LIMITED
Company type
Private Limited Company
Region
South East England
Registered address
SUSSEX INNOVATION CENTER SCIENCE PARK SQUARE
FALMER
BRIGHTON
SUSSEX
BN1 9SB
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 2 ultimate controllers
1
Company Active LTD
Psephos Limited
CRN 04148007
2
Direct and ultimate controller Active LTD
3
Direct and ultimate controller Active LTD
Ten10 Life Limited
CRN 13306512

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
6

Company events

Reference milestones and recent Companies House filing stream events.

5 events
31 Dec
2027

Accounts due

Accounts Due

Next accounts due date

09 Dec
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Mar
2026

Accounts filed

Accounts

Last accounts made up date

25 Nov
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

25 Jan
2001

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2024
Funded years
2024, 2025
Age at first award
23 years

Projects

2025 Collaborative R&D Lead participant

CLEARED (CLinical Evaluation & Assessment for REgulation of Diagnostic tests) Implementation Phase

1 Feb 2025 to 31 Mar 2026

Awarded
£144,833
Total cost £144,833

Our network will focus on assisting the efficient and safe availability of medical diagnostic tests in the UK, by building a collaborative network of regulators, industry, people living with disease and users of tests and researchers. Efficient regulation of diagnostic tests not only assists patient and consumer safety, but also improves the nation's heal...

2024 Collaborative R&D Lead participant

CLinical Evaluation & Assessment for REgulation of Diagnostic tests

1 Mar 2024 to 31 Aug 2024

Awarded
£39,777
Total cost £39,777

Our network will focus on assisting the efficient and safe availability of medical diagnostic tests in the UK, by building a collaborative network of **regulators, industry, people living with disease and users of tests** **and researchers**. Efficient regulation of diagnostic tests not only assists patient and consumer safety, but also improves the natio...

Product types

Collaborative R&D